Glaucoma News

Massive Eye Drop Recall Exposes Critical FDA and Manufacturing Failures A recent, sweeping recall of over two dozen brands of eye drops has done more than just clear pharmacy shelves. It has ripped the bandage off a festering wound in the U.S. healthcare system: critical failures in pharmaceutical manufacturing oversight and a strained Food and […]

AIIMS Proposes Lactoferrin Milk Protein Tablet for Dry Eye Relief For millions grappling with the persistent discomfort of dry eye disease, relief has often been a revolving door of eye drops, gels, and lifestyle adjustments. Now, a groundbreaking proposal from one of India’s premier medical institutions, the All India Institute of Medical Sciences (AIIMS), is

Amgen’s On-Body Injector for Tepezza Succeeds in Thyroid Eye Disease Trial For patients battling the painful and vision-threatening symptoms of Thyroid Eye Disease (TED), the breakthrough drug Tepezza (teprotumumab) has been a game-changer. However, its administration—eight separate 90-minute IV infusions over several months—has been a significant logistical hurdle. Now, a new chapter is beginning. Amgen

Abia Community Receives Free Eye Care and Glasses for 216 Beneficiaries In a heartwarming display of community-focused healthcare, a recent medical outreach in Abia State has brought the gift of clear vision to hundreds of residents. The initiative, which provided comprehensive eye screenings and free prescription glasses, directly impacted 216 beneficiaries, offering them not just

California’s Child Vision Care Crisis Is Deepening For many of California’s children, the world is literally out of focus, and the problem is growing worse. A silent epidemic of untreated vision issues is sweeping through the state’s youngest generation, with profound consequences for their education, development, and future. Despite California’s reputation as a leader in

FDA Recalls Eye Drops Sold Nationwide, Including San Antonio In a significant move to protect public health, the U.S. Food and Drug Administration (FDA) has issued a nationwide recall for several brands of over-the-counter eye drops. The alert, issued in early April 2026, specifically names products that were distributed and sold in major retailers across

The Future of Cataract Surgery: 2026 Innovations and Breakthroughs The landscape of ophthalmology is undergoing a radical transformation. As we stand in 2026, cataract surgery is no longer just a procedure to restore vision; it has evolved into a pinnacle of precision medicine, artificial intelligence, and personalized patient care. Driven by relentless innovation, the operating

Major Eye Drop Recall: Over 3 Million Bottles Pulled Nationwide A significant and urgent recall has been issued for several brands of eye drops, with more than 3 million bottles being pulled from store shelves and online retailers across the United States. This sweeping action, impacting products sold at major national chains, underscores a critical

California’s Children Face a Growing Crisis in Vision Care Access For over 1.5 million low-income children in California, seeing the world clearly—and succeeding in it—is becoming an uphill battle. These children rely on Medi-Cal, the state’s Medicaid program, for essential health services, including vision care. However, a systemic and growing crisis in access to eye